CaHA-based collagen stimulators are carving out a distinct clinical position in the aesthetic medicine market. Even within the same collagen-stimulator category, product selection and treatment design diverge depending on whether the goal is volume or skin quality improvement, making the question of which patient to treat with CaHA, and for what purpose, an increasingly nuanced clinical judgment. Dr. Kiwoong Yu of Maylin Clinic's Jamsil Lotte Hotel branch, who has used this CaHA product line since its earlier VoLassom era, views CaHA as a treatment positioned more toward rejuvenation than volume. He explains that CaHA suits patients who need a modest degree of volume alongside skin quality improvement, and that the keys to nodule prevention lie in proper dilution and even product distribution. From patient selection criteria to mixing and layer design, combination with energy-based devices, and safety management, Dr. Yu shares his clinical experience.
#MedicalAestheticNews #DNCAesthetics #DCLASSYCaHA #Facetem #DrKiwoongYu #MaylinClinicJamsilLotteHotel
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20076

Comments
Post a Comment